Exosomal integrins in tumor progression, treatment and clinical prediction (Review)

29Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

Abstract

Integrins are a large family of cell adhesion molecules involved in tumor cell differentiation, migration, proliferation and neovascularization. Tumor cell‑derived exosomes carry a large number of integrins, which are closely associated with tumor progression. As crucial mediators of intercellular communication, exosomal integrins have gained attention in the field of cancer biology. The present review examined the regulatory mechanisms of exosomal integrins in tumor cell proliferation, migration and invasion, and empha‑ sized their notable roles in tumor initiation and progression. The potential of exosomal integrins as drug delivery systems in cancer treatment was explored. Additionally, the potential of exosomal integrins in clinical tumor prediction was consid‑ ered, while summarizing their applications in diagnosis, prognosis assessment and treatment response prediction. Thus, the present review aimed to provide guidance and insights for future basic research and the clinical translation of exosomal integrins. The study of exosomal integrins is poised to offer new perspectives and methods for precise cancer treatment and clinical prediction.

Cite

CITATION STYLE

APA

Shen, Y. Q., Sun, L., Wang, S. M., Zheng, X. Y., & Xu, R. (2024, December 1). Exosomal integrins in tumor progression, treatment and clinical prediction (Review). International Journal of Oncology. Spandidos Publications. https://doi.org/10.3892/ijo.2024.5706

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free